Stocks
Nasdaq Growth
Nasdaq-100 exposure focused on innovation leaders.
Concentrated allocation to the largest non-financial companies listed on the Nasdaq. Suited for investors seeking growth-oriented equity exposure benchmarked to the QQQ.
Plan terms
- Target ROI
- 22%
- Term length
- 45 days
- Minimum
- $500
- Maximum
- $250,000
- Strategy
- Growth-tilt, concentrated top-100 Nasdaq names, monthly review.
Benchmark performance
Cumulative return · last 12 months
Allocation
Portfolio breakdown
Holdings
Top positions and weights
Why investors choose this plan
- Direct exposure to US technology leaders
- Monthly review of concentration risk
- Benchmarked against the Nasdaq-100 (QQQ)
- Fixed 22% target ROI over 45 days
Risks to consider
- Concentrated in a small number of high-beta names
- Growth stocks are sensitive to interest-rate shifts
- Capital is locked for the plan term
Ready to invest in Nasdaq Growth?
Open an investor account, complete verification, and fund your wallet in minutes.